Assayag, Franck <br/><br/>
Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab.  [electronic resource] 

 -  American journal of hematology  Jun 2009 
 - 387-8 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.21415  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD20--immunology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Doxycycline--administration & dosage<br/>Humans<br/>Immunohistochemistry<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Mice<br/>Mice, SCID<br/>Rituximab<br/>Xenograft Model Antitumor Assays